Biosimilars Analytical Strategies

Analysis of Biosimilars and biologics forms to be one of the most important aspect towards the biologics and biosimilar development process. The development pathway of a biosimilar is unlike that of a novel biotherapeutic, requiring earlier extensive analytical characterization. Analysis of biosimilar and biologics takes the longest stretch towards establishing the product in comparison with the original product.

Any manufacturer seeking to develop and market a biopharmaceutical product requires comprehensive physicochemical structural characterization of the (glyco) protein. For biosimilar products, this task is magnified and forms the basis for further comparability. 

  • Biosimilar Bioanalytical methods
  • Biosimilar Formulation
  • Bioassay for comparability and potency testing
  • Biosimilar GMP protein analysis
  • Biosimilar LC/MS analysis for discovery, preclinical, and clinical programs
  • Biosimilar Electrophoresis
  • Biosimilar Multimodal techniques
  • Bioanalytical Challenges

Related Conference of Biosimilars Analytical Strategies

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson Toronto Airport West, 175 Derry Road East, Mississauga, ON, L5T 2Z7, Canada
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15 | 2018

13th International Conference on Biosimilars and Biologics

Lisbon | Portugal
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Biosimilars Analytical Strategies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in